Surrey Heartlands

Joint Formulary & PAD

Viper antivenom - Envenomation by Vipera Berus

You are here : Home > Formulary Search > Viper antivenom - Envenomation by Vipera Berus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
https://www.toxbase.org/

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Viper antivenom
Indication :
Envenomation by Vipera Berus
Group Name :
Keywords :
snake venom, snake bite antivenom, viper antiserum, European adder, Vipera berus, snake venom antiserum
Brand Names Include :
ViperaTab, Viperfav
Important Information :
https://www.toxbase.org/ . Unlicensed. Store in the fridge. Can be ordered from Public Health England (PHE) by email vaccinesupply@phe.gov.uk
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Viper antivenom is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Envenomation by Vipera Berus.

  • No records returned.

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.